chr2-190659798-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005966.4(NAB1):c.622C>T(p.Pro208Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005966.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAB1 | ENST00000337386.10 | c.622C>T | p.Pro208Ser | missense_variant | 4/10 | 1 | NM_005966.4 | ENSP00000336894.5 | ||
NAB1 | ENST00000409641.5 | c.622C>T | p.Pro208Ser | missense_variant | 1/7 | 1 | ENSP00000386682.1 | |||
NAB1 | ENST00000409581.5 | c.622C>T | p.Pro208Ser | missense_variant | 2/8 | 2 | ENSP00000387089.1 | |||
NAB1 | ENST00000434473.1 | c.-33C>T | upstream_gene_variant | 2 | ENSP00000390914.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251352Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135862
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461854Hom.: 0 Cov.: 33 AF XY: 0.0000509 AC XY: 37AN XY: 727226
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2022 | The c.622C>T (p.P208S) alteration is located in exon 4 (coding exon 1) of the NAB1 gene. This alteration results from a C to T substitution at nucleotide position 622, causing the proline (P) at amino acid position 208 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at